Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia

Diabetologia

Volumn 41, Issue 5, 1998, Pages 589-594

  Frystyk, J ^a   Skjaerbaek C ^a   Zapf, J ^b   Orskov H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Free IGF I; Free IGF II; IGFBPs; NICTH; Total IGF I; Total IGF II

Indexed keywords

BIOCHEMICAL MARKER; GROWTH HORMONE; INSULIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN LIKE ACTIVITY; MALE; NEGATIVE FEEDBACK; PANCREAS TUMOR; PRIORITY JOURNAL;

ADENOMA, ISLET CELL; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; HYPOGLYCEMIA; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE;

EID: 0031980093     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050951     Document Type: Article

References (31)

1. Kahn CR (1980) The riddle of tumour hypoglycaemia revisited. Clin Endocrinol Metab 9: 335-360
2. Bach LA, Rechler MM (1995) Insulin-like growth factor binding proteins. Diabetes Rev 3: 38-61
3. Zapf J (1995) Insulin-like growth factor binding-proteins and tumor hypoglycemia. Trends Endocrinology Metabolism 6:37-42
4. Daughaday WH (1995) The pathophysiology of IGF-II hypersecretion in non-islet cell tumor hypoglycemia. Diabetes Rev 3: 62-72
5. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ, Braund W (1995) Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 80:2700-2708
6. Zumstein PP, Luthi C, Humbel RE (1985) Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc Natl Acad Sci U S A 82: 3169-3172
7. Daughaday WH, Kapadia M (1989) Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci U S A 86:6778-6782
8. Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS (1990) Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. J Clin Invest 85:1672-1679
9. Zapf J, Futo E, Peter M, Froesch ER (1992) Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 90: 2574-2584
10. Zapf J (1995) Physiological role of the insulin-like growth factor binding proteins. Eur J Endocrinol 132:645-654
11. Frystyk J, Skjærbæk C, Dinesen B, Ørskov H (1994) Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters 348: 185-191
12. Daughaday WH, Trivedi B, Baxter RC (1995) Abnormal serum IGF-II transport in non-islet cell tumor hypoglycemia results from abnormalities of both IGF binding protein-3 and acid labile subunit and leads to elevation of free IGF-II. Endocrine 3:425-430
13. Zapf J, Schmid C, Guler HP et al. (1990) Regulation of binding proteins for insulin-like growth factors (IGF) in humans. Increased expression of IGF binding protein 2 during IGF I treatment of healthy adults and in patients with extrapancreatic tumor hypoglycemia. J Clin Invest 86: 952-961
14. Bereket A, Lang CH, Blethen SL, Wilson TA (1995) Insulin-like growth factor-binding protein-2 and insulin: studies in children with type 1 diabetes mellitus and maturity-onset diabetes of the young. J Clin Endocrinol Metab 80:3647-3652
15. Lee PD, Conover CA, Powell DR (1993) Regulation and function of insulin-like growth factor-binding protein-I. Proc Soc Exp Biol Med 204: 4-29
16. Baxter RC, Daughaday WH (1991) Impaired formation of the ternary insulin-like growth factor-binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J Clin Endocrinol Metab 73:696-702
17. Binoux M, Hossenlopp P (1988) Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67: 509-514
18. Frystyk J, Grøfte T, Skjærbæk C, Ørskov H (1997) The effect of oral glucose on serum free insulin-like growth factor-I and -II in healthy adults. J Clin Endocrinol Metab 82:3124-3127
19. Møller N, Frystyk J, Skjaærbæk C et al. (1996) Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors. Diabetologia 39: 534-535
20. Frystyk J, Dinesen B, Ørskov H (1995) Non-competitive time-resolved immunofluorometric assay for determination of human insulin-like growth factor I and II. Growth Regul 5:169-176
21. Frystyk J, Grønbæk H, Skjærbæk C, Flyvbjerg A (1995) Effect of hyperthyroidism on circulating levels of free and total IGF-I and IGFBPs in rats. Am J Physiol 269:E840-E845
22. Hizuka N, Takano K, Asakawa K et al. (1991) Measurement of free form of insulin-like growth factor I in human plasma. Growth Regul 1:51-55
23. Frystyk J, Vestbo E, Skjærbæk C, Mogensen CE, Ørskov H (1995) Free insulin-like growth factors in human obesity. Metabolism 44 (suppl 4):37-44
24. Kaal A, Frystyk J, Skjærbæk C et al. (1995) Effects of intramuscular microsphere-encapsulated octreotide on serum growth hormone, insulin-like growth factors (IGFs), free IGFs, and IGF-binding proteins in acromegalic patients. Metabolism 44 (suppl. 1):6-14
25. Skjæbæk C, Vahl N, Frystyk J et al. (1997) Serum free insulin-like growth factor-I in growth hormone deficient adults before and after growth hormone replacement. Eur J Endocrinol 132: 132-137
26. Zapf J, Hauri C, Futo E et al. (1995) Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. J Clin Invest 95:179-186
27. Hunter SJ, Daughaday WH. Callender ME et al. (1994) A case of hepatoma associated with hypoglycaemia and over-production of IGF-II (E-21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clin Endocrinol (Oxf) 41: 397-401
28. Teale JD, Blum WF, Marks V (1992) Alleviation of non-islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF binding protein-3. Ann Clin Biochem 29:314-323
29. Poggi C, Le Marchand Brustel Y, Zapf J, Froesch ER, Freychet P (1979) Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology 105: 723-730
30. Weber MM, Melmed S, Rosenbloom J, Yamasaki H, Prager D (1992) Rat somatotroph insulin-like growth factor-II (IGF-II) signaling: role of the IGF-I receptor. Endocrinology 131:2147-2153
31. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16: 3-34